NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/07/2026
Voltar para busca
Dado oficial do USPTO
PERNAULTRA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
30/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 29
Data de depósito
28/08/2020
Data de registro
15/11/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/11/2022
Última transação
30/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
NZ
Examinador
PEETE, KYLE C
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SANFORD LIMITED
Representantes
Jeff Goehring Nixon & Vanderhye P.C.
Classificação técnica
Classes Nice
Classe 5Classe 29
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Marine extracts for pharmaceuticalmedicinalveterinary purposes; marine extracts for dietetic and nutritional use in humans and animals; dietary supplements for humans and animals; nutritional supplements for humans and animals; food supplements for humans and animals; shellfish extracts for use as an ingredient in dietary and nutritional supplements; mussel extractsincluding mussel powders and water soluble mussel extracts for pharmaceuticalmedicinalveterinary purposes; mussel extractsincluding mussel powders and water soluble mussel extracts for dietetic and nutritional use; stabilized freeze dried mussel powders for medicinal purposes; mussel powders for use in joint care formulations and anti-inflammatory preparations; protein supplements; mussel extracts for use as an ingredient in dietary and nutritional supplements; natural healthcare preparations in the nature of mussel extracts for medical purposes; green-lipped mussel extracts and powders for use as dietary supplements and nutritional supplements or medicinal purposes; all the foregoing consistingin substantial partof protein and lipids extracted from perna canaliculus
Classe 29
Extracts derived or extracted from marine animalsshellfish; powders derived or extracted from marine animalsshellfish; seafood extracts; shellfish extracts for use as foodstuffs not for dietary and nutritional supplements and medicinal purposes; mussel extracts; stabilized freeze-dried mussel powder products in the nature of powders derived or extracted from marine animals; water soluble mussel powder products in the nature of powders derived or extracted from marine animals; extracts derived from green-lipped mussels not for medicinal purposes; green-lipped mussel oil extract for use as an ingredient in foodstuff; all the foregoing consistingin substantial partof protein and lipids extracted from perna canaliculus
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/03/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/03/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/03/2023
FIMP
FINAL DISPOSITION PROCESSED
08/03/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
15/02/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
15/11/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
15/11/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
14/11/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/10/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
26/10/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/08/2022
PUBO
PUBLISHED FOR OPPOSITION
30/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/05/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
16/05/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
16/02/2022
GNFR
FINAL REFUSAL E-MAILED
16/02/2022
CNFR
FINAL REFUSAL WRITTEN
16/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/12/2021
RFNT
REFUSAL PROCESSED BY IB
11/07/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/06/2021
RFRR
REFUSAL PROCESSED BY MPU
21/06/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/06/2021
CNRT
NON-FINAL ACTION WRITTEN
15/06/2021
MAFR
APPLICATION FILING RECEIPT MAILED
26/05/2021
DOCK
ASSIGNED TO EXAMINER
22/05/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/05/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/05/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PERNAULTRA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.